Who owns Evogene Ltd., from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
L.I.A. Pure Capital Ltd.: 19.4% · 3,057,488 shares — Kfir Silberman: 19.4% · 3,057,488 shares — Invest Pro Shukai Hon Ltd.: 19.4% · 3,057,488 shares
Armistice Capital, LLC: 5.0% · 713,539 shares — Steven Boyd: 5.0% · 713,539 shares
1 more 5% stakes behind a free account
See every investor who has disclosed crossing 5% of Evogene Ltd..
Sign up freeEvery institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Evogene Ltd. they hold. Together these 22 managers report 7.93% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $352K | 456,587 | 0.01% | 5.24% | March 31, 2026 |
| HRT FINANCIAL LP | $45K | 107,198 | 0.00% | 1.23% | June 30, 2026 |
20 more institutional holders behind a free account
See every manager reporting Evogene Ltd., how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 0 funds hold 0.00% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
No fund on record discloses this stock yet.
Loading...
